Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+17.95%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$10.2B
AUM Growth
+$1.96B
(+24%)
Cap. Flow
+$684M
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
43.19%
Holding
1,081
New
132
Increased
418
Reduced
456
Closed
74
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$295M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$118M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$97.9M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$55.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$27.6M |
Top Sells
| 1 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$107M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$32.9M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$17.7M |
| 4 |
Lockheed Martin
LMT
|
+$13.5M |
| 5 |
Apple
AAPL
|
+$10.9M |
Sector Composition
| 1 | Technology | 26.66% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 3.24% |
| 4 | Energy | 3.1% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Plug Power
PLUG
$1.63B
| $783K | 0.01% |
+23,081
| New | +$783K |
|
|
VBIV
577
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $780K | 0.01% |
9,450
-11,748
| -55% | -$970K |
|
578
Insmed
INSM
$31.1B
| $778K | 0.01% |
23,371
-46,314
| -66% | -$1.54M |
|
579
Esperion Therapeutics
ESPR
$512M
| $776K | 0.01% |
29,861
-22,575
| -43% | -$587K |
|
580
Madrigal Pharmaceuticals
MDGL
$10B
| $775K | 0.01% |
6,974
-3,532
| -34% | -$393K |
|
581
Target
TGT
$41.3B
| $773K | 0.01% |
4,378
+702
| +19% | +$124K |
|
582
Realty Income
O
$54.4B
| $770K | 0.01% |
12,786
+592
| +5% | +$35.7K |
|
583
Yelp
YELP
$2B
| $769K | 0.01% |
+23,526
| New | +$769K |
|
584
AAR Corp
AIR
$2.66B
| $768K | 0.01% |
21,216
+901
| +4% | +$32.6K |
|
585
JELD-WEN Holding
JELD
$529M
| $767K | 0.01% |
30,247
-6,789
| -18% | -$172K |
|
586
Veracyte
VCYT
$2.52B
| $762K | 0.01% |
15,566
-29,405
| -65% | -$1.44M |
|
587
Agilent Technologies
A
$35.8B
| $755K | 0.01% |
6,370
-104
| -2% | -$12.3K |
|
588
Ironwood Pharmaceuticals
IRWD
$180M
| $754K | 0.01% |
66,227
-128,435
| -66% | -$1.46M |
|
589
American Superconductor
AMSC
$2.25B
| $753K | 0.01% |
+32,173
| New | +$753K |
|
|
ICPT
590
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $750K | 0.01% |
30,355
-17,226
| -36% | -$426K |
|
591
Ventas
VTR
$31B
| $748K | 0.01% |
15,257
-245
| -2% | -$12K |
|
592
A10 Networks
ATEN
$1.26B
| $747K | 0.01% |
+75,717
| New | +$747K |
|
593
Q32 Bio
QTTB
$21.7M
| $746K | 0.01% |
+3,671
| New | +$746K |
|
594
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $736K | 0.01% |
42,327
-58,629
| -58% | -$1.02M |
|
|
CADE
595
DELISTED
Cadence Bancorporation
CADE
| $735K | 0.01% |
44,790
-33,372
| -43% | -$548K |
|
|
BLDP
596
Ballard Power Systems
BLDP
$568M
| $734K | 0.01% |
+31,357
| New | +$734K |
|
597
Kura Oncology
KURA
$695M
| $732K | 0.01% |
22,398
-6,207
| -22% | -$203K |
|
598
Deere & Co
DE
$129B
| $729K | 0.01% |
2,708
-5,436
| -67% | -$1.46M |
|
599
Sturm, Ruger & Co
RGR
$569M
| $728K | 0.01% |
11,182
+477
| +4% | +$31.1K |
|
600
Heron Therapeutics
HRTX
$199M
| $717K | 0.01% |
33,872
-75,112
| -69% | -$1.59M |
|